Level of evidence*Clinical implications
AFOBT performed every two years is effective in reducing colorectal cancer mortality but less so than annual testing.
AFOBT reduces the incidence of colorectal cancer.
BBarium enema sensitivity is lower than previously estimated.
BColonoscopy is more accurate than flexible sigmoidoscopy and
FOBT for detecting colorectal neoplasia, but the implications for screening policy are unclear.
BDNA stool test and virtual colonoscopy show early promise for
detection of colorectal neoplasia, but further research is required.
AIncreased fiber intake does not prevent recurrent colorectal adenomas in middle-aged adults.
ACalcium supplements reduce the risk of recurrent colorectal adenomas.
ANSAIDs, including COX-2 inhibitors, reduce the risk of adenomas in patients with high-risk familial syndromes.